The Global Contrast Media Injectors Market By Product (Injector Systems (CT Injector, MRI Injector), Consumables (Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) – Global Forecast to 2025″, size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025.Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959
Browse in-depth TOC on “Contrast Media Injectors Market”
226 – Tables
25 – Figures
163 – Pages
Drivers: Increasing prevalence of Cancer and CVD
Globally, there has been a significant increase in the number of people suffering from cancer.the number of people suffering from cancer is expected to increase by 50% to 15 million by 2020 (Source: World Cancer Report, 2003 by WHO). Similarly, CVDs and strokes are the leading causes of death around the world. According to the World Health Organization (WHO), CVDs are the major cause of death globally. The WHO estimated that in 2015, approximately 17.7 million people died of CVDs, which represented 31% of the global deaths; this number is estimated to increase to 23.6 million by 2030. Contrast media injectors are used to inject contrast media at the time of diagnostic imaging to enhance image quality and improve patient safety. Thus, the increase in the number of cancer and CVD cases will stimulate the demand for improved healthcare facilities and advanced diagnostic imaging procedures, which, in turn, will drive the market for contrast media injectors.
Restraints: High cost of contrast media injectors, consumables and accessories
The cost of contrast media injectors varies with the type of injectors (single-head, dual-head, and syringeless injectors) preferred by hospitals. For instance, the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector – Pedestal Mount costs ~USD 40,600, while the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector – Ceiling Mount for Long costs around USD 45,000. The cost of consumables is recurring as the same tube and syringe cannot be reused, considering hygiene and safety issues. This is a major burden for end users, as tubes and syringes cost USD 350–500 each, thus escalating the cost of using contrast media injector systems.
Opportunities: IT-enabled solutions for contrast media injectors
Contrast media injectors are now enabled with an LCD screen to maintain flow rates and monitor patient status. Also, market players are introducing new software for injector systems that can generate data in real-time. Information such as contrast media flow rate, injection pressure, injection speed, and type of contrast media can be easily accessed through this software. The IT department of a hospital can connect this software directly to their hospital information systems or electronic medical records and access patient data from picture archiving and communication systems. This reduces the time, error rate, and effort to upload statistical data and images manually.
Challenges: Dearth of trained professionals
A high degree of technical skill and expertise is required to handle advanced and sophisticated diagnostic imaging systems. According to the US Bureau of Labor Statistics, radiology technicians may witness employment growth of about 21% between 2012 and 2022. Although this is significant, the dearth of specialists and radiologists is an important challenge for countries across the globe
Key Market Players
The major players in the contrast media injector industry are Bayer Ag (Germany), Bracco Imaging S.p.A (Italy), and Guerbet Group (France). An analysis of the market developments between 2016 and 2019 revealed that product launches, partnerships, expansions, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the contrast media injector market.
Bayer was the leading player in the contrast media injector market in 2019. The company offers a comprehensive range of contrast media injectors. Bayer has a strong focus on innovation and invested USD 6.2 billion in research and development in 2018. The company’s strong focus on R&D has led to the innovation of products. For instance, in February 2018, Bayer launched the new Medrad Centargo CT injection system. Additionally, in July 2019, the US FDA approved Bayer’s Gadavist as the first contrast agent for cardio MRI, which will lead to significant demand for contrast injector in the space of cardiac magnetic resonance (MR) imaging.
Bracco Imaging S.p.A held the second position in the contrast media injector market in 2019. The company maintains a direct sales force to reach out to its customers. To maintain its strong position in the market, in November 2016, the company received US FDA approval for its CT Exprès 3D Contrast Media Delivery System. It succeeded in creating a strong foothold in the market, owing to its diversified product portfolio, broad geographic reach, and focus on acquisitions and product launches.
Guerbet Group held the third position in the contrast media injector market in 2019. The company offers an extensive portfolio of contrast media injectors under various categories (including CT, MRI, Angiography injectors). The company has a strong presence in EMEA (Europe, the Middle East, and Africa) countries followed by North America, APAC, and LATAM. The company has been focusing on innovation and received an award for its contrast media injector products in 2015. The company also launched Optivantage multi-use injector for injecting contrast agents used in X-ray medical examinations in November 2018.
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=96046959
North America will continue to dominate the contrast media injector market during the forecast period
Geographically, North America dominated the contrast media injector market in 2019, while Asia Pacific is expected to register the highest CAGR during the forecast period. The large share of North America is attributed to the increasing number of diagnostic imaging units & examinations, rising aging population & corresponding disease conditions in the US, significant focus & government investments in the medical imaging arena, and increasing research activities in Canada.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96046959
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/contrast-injector-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/contrast-injector.asp
